Title: Is DEB-TACE  as  locoregional  therapy  before  liver  transplantation  for  hepatocellular
  carcinoma effective?
Version: 3 Date: 12 Jul 2024
Reviewer:  Islam H. Shawali
Reviewer's report:
Dear authors, I have read your paper with great interest.
In my opinion,  the study addresses an important patients group with a good approach to improve
prognostic predictions.
However it is difficult to understand how the DEB-TACE applied pre-transplanatation  can be
referred as an effective and safe option for HCC wihtout considering the PVTT and child pugh.
Are other types of LRT applicable in such group of patients and if not you should have refereed
to the edge  that DEB-TACE has in such cases
Inclusion and exclusion criteria have to be more clear.
There is no enough data concerning if the differentiation of the tumor affected the results.
Title: Is DEB-TACE  as  locoregional  therapy  before  liver  transplantation  for  hepatocellular
  carcinoma effective?
Version: 3 Date: 12 Jul 2024
Reviewer:  Islam H. Shawali
Reviewer's report:
Dear authors, I have read your paper with great interest.
In my opinion,  the study addresses an important patients group with a good approach to improve
prognostic predictions.
However it is difficult to understand how the DEB-TACE applied pre-transplanatation  can be
referred as an effective and safe option for HCC wihtout considering the PVTT and child pugh.
Are other types of LRT applicable in such group of patients and if not you should have refereed
to the edge  that DEB-TACE has in such cases
Inclusion and exclusion criteria have to be more clear.
There is no enough data concerning if the differentiation of the tumor affected the results.
Please review this paper.
user
Title: Is DEB-TACE  as  locoregional  therapy  before  liver  transplantation  for  hepatocellular
  carcinoma effective?
Version: 3 Date: 12 Jul 2024
Reviewer:  Islam H. Shawali
Reviewer's report:
Dear authors, I have read your paper with great interest.
In my opinion,  the study addresses an important patients group with a good approach to improve
prognostic predictions.
However it is difficult to understand how the DEB-TACE applied pre-transplanatation  can be
referred as an effective and safe option for HCC wihtout considering the PVTT and child pugh.
Are other types of LRT applicable in such group of patients and if not you should have refereed
to the edge  that DEB-TACE has in such cases
Inclusion and exclusion criteria have to be more clear.
There is no enough data concerning if the differentiation of the tumor affected the results.
assistant